{
    "2018-09-10": [
        [
            {
                "time": "",
                "original_text": "复星医药：控股子公司获药品临床试验批准",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "药品",
                        "临床试验",
                        "批准"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-09-10",
                "original_text": "A股市场资金变动一览（9月10日）",
                "features": {
                    "keywords": [
                        "A股",
                        "市场",
                        "资金",
                        "变动"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[公司信息]【增减持】复星医药(02196.HK)获Wellington Management Group LLP增持2.75万股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "增持",
                        "Wellington Management Group LLP",
                        "港股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "证监会年内首批两公司QFII资格大数据揭秘外资长期投资图谱",
                "features": {
                    "keywords": [
                        "证监会",
                        "QFII",
                        "资格",
                        "大数据",
                        "外资",
                        "长期投资"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}